Post-marketing surveillance found out-of-specification results in the hypertension medicine; the Class II recall covers four batches of 28-tablet packs, two of which remain in…
The order covers YENISOM Healthcare's entire range rather than named batches, and the agency says the ground is procedural: required entry testing was not…